New Series: SOHO 'State of the Art Updates and Next Questions'

被引：0
|
作者：
Kantarjian, Hagop [1 ,2 ]
Talpaz, Moshe [1 ,3 ,4 ,5 ]
机构：
[1] Soc Hematol Oncol, The Woodlands, TX 77393 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Michigan, Sch Med, Leukemia Res, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Translat Res, Ann Arbor, MI USA
[5] Univ Michigan, Sch Med, Hematol Oncol, Ann Arbor, MI USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 08期
关键词：
D O I：
10.1016/j.clml.2017.06.036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：463 / 463
页数：1
相关论文
共 50 条
  • [41] SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCL
    Brazel, Danielle
    Pinter-Brown, Lauren
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (06): : 401 - 409
  • [42] SOHO State-of-the-Art Update and Next Questions: MPN
    Bose, Prithviraj
    Gotlib, Jason
    Harrison, Claire N.
    Verstovsek, Srdan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : 1 - 12
  • [43] SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenstrom Macroglobulinemia
    Sermer, David
    Sarosiek, Shayna
    Branagan, Andrew R.
    Treon, Steven P.
    Castillo, Jorge J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (08): : 547 - 556
  • [44] SOHO State of the Art Updates and Next Questions: Pathology and Pathogenesis of Nodal Peripheral T-Cell Lymphomas
    Qiu, Lianqun
    Cho, Jeong Hee
    Jelloul, Fatima Zahra
    Vega, Francisco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05): : 287 - 296
  • [45] SOHO State of the Art Updates and Next Questions |Treatment Approaches for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Binkley, Michael S.
    Advani, Ranjana H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (07): : 471 - 476
  • [46] SOHO State of the Art Updates and Next Questions: The Past, Present and Future of Venetoclax-Based Therapies in AML
    Inguva, Anagha
    Pollyea, Daniel A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (12): : 805 - 811
  • [47] SOHO State of the Art Updates and Next Questions: The Conundrum in Assessing the Therapy Response of Patients With Chronic Lymphocytic Leukemia
    Choi, Michael Y.
    Wang, Huan-You
    Kipps, Thomas J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (06): : 321 - 325
  • [48] SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: "Per Aspera Ad Astra"
    Abruzzese, Elisabetta
    Trawinska, Malgorzata Monika
    De Fabritiis, Paolo
    Bernardi, Simona
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04): : 214 - 223
  • [49] SOHO State of the Art Updates and Next Questions: BTK inhibitors combined with chemoimmunotherapy in CLL, the best of both worlds?
    Thompson, Philip A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (04): : 205 - 209
  • [50] SOHO State of the Art Updates and Next Questions | Optimal Timing of Blinatumomab for the Treatment of B-Acute Lymphoblastic Leukemia
    Pinchinat, Ashley
    Gupta, Sumit
    Cooper, Stacy L.
    Rau, Rachel E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (03): : 159 - 167
12345